349 related articles for article (PubMed ID: 35758682)
1. Plasma Virome Reveals Blooms and Transmission of Anellovirus in Intravenous Drug Users with HIV-1, HCV, and/or HBV Infections.
Li Y; Cao L; Ye M; Xu R; Chen X; Ma Y; Tian RR; Liu FL; Zhang P; Kuang YQ; Zheng YT; Zhang C
Microbiol Spectr; 2022 Aug; 10(4):e0144722. PubMed ID: 35758682
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Infection Alters the Viral Composition of Plasma in Men Who Have Sex with Men.
Liu K; Li Y; Xu R; Zhang Y; Zheng C; Wan Z; Li H; Yang Z; Jin X; Hao P; Zhao J; Zhang C
mSphere; 2021 May; 6(3):. PubMed ID: 33952659
[TBL] [Abstract][Full Text] [Related]
3. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
4. Human Anelloviruses: Influence of Demographic Factors, Recombination, and Worldwide Diversity.
Cebriá-Mendoza M; Beamud B; Andreu-Moreno I; Arbona C; Larrea L; Díaz W; Sanjuán R; Cuevas JM
Microbiol Spectr; 2023 Jun; 11(3):e0492822. PubMed ID: 37199659
[TBL] [Abstract][Full Text] [Related]
5. Virome analysis of antiretroviral-treated HIV patients shows no correlation between T-cell activation and anelloviruses levels.
Li L; Deng X; Da Costa AC; Bruhn R; Deeks SG; Delwart E
J Clin Virol; 2015 Nov; 72():106-13. PubMed ID: 26479202
[TBL] [Abstract][Full Text] [Related]
6. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya.
Webale MK; Budambula V; Lihana R; Musumba FO; Nyamache AK; Budambula NL; Ahmed AA; Ouma C; Were T
BMC Infect Dis; 2015 Jul; 15():299. PubMed ID: 26223795
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
[TBL] [Abstract][Full Text] [Related]
9. Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome.
Arze CA; Springer S; Dudas G; Patel S; Bhattacharyya A; Swaminathan H; Brugnara C; Delagrave S; Ong T; Kahvejian A; Echelard Y; Weinstein EG; Hajjar RJ; Andersen KG; Yozwiak NL
Cell Host Microbe; 2021 Aug; 29(8):1305-1315.e6. PubMed ID: 34320399
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
11. Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region.
Zhou YH; Liu FL; Yao ZH; Duo L; Li H; Sun Y; Zheng YT
PLoS One; 2011 Jan; 6(1):e16349. PubMed ID: 21283696
[TBL] [Abstract][Full Text] [Related]
12. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
[TBL] [Abstract][Full Text] [Related]
13. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.
Zhou YH; Yao ZH; Liu FL; Li H; Jiang L; Zhu JW; Zheng YT
PLoS One; 2012; 7(8):e42937. PubMed ID: 22916185
[TBL] [Abstract][Full Text] [Related]
15. Plasma virome and the risk of blood-borne infection in persons with substance use disorder.
Kandathil AJ; Cox AL; Page K; Mohr D; Razaghi R; Ghanem KG; Tuddenham SA; Hsieh YH; Evans JL; Coller KE; Timp W; Celentano DD; Ray SC; Thomas DL
Nat Commun; 2021 Nov; 12(1):6909. PubMed ID: 34824209
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
17. Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics.
Chen M; Ma Y; Chen H; Luo H; Dai J; Song L; Yang C; Mei J; Yang L; Dong L; Jia M; Lu L
PLoS One; 2015; 10(11):e0142543. PubMed ID: 26562015
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
19. Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users.
Kato H; Maeno Y; Seko-Nakamura Y; Monma-Ohtaki J; Sugiura S; Takahashi K; Zhe LX; Matsumoto T; Kurvanov F; Mizokami M; Nagao M
Forensic Sci Int; 2007 May; 168(1):27-33. PubMed ID: 16829004
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
